Table 4. CD4 T-lymphocyte counts (basic model M1), HIV VL (M6 model), and HAART with PI (M7 model) effects on probability of HPV clearance, by phylogenetic HPV group, in HIV-1-infected adolescent females, REACH cohort.

HPV type	Model	u00 (SE)	β00 (SE)a	u11 (SE)	β11 (SE)a	Additional parameter in the model (SE)
16/16-like	M1	−3.5±0.15**	−0.14±0.25	−1.52±0.15**	1.15±0.27**	––
	M6	−3.47±0.17**	−0.09±0.28	−0.7±0.47*	0.79±0.35**	−0.17±0.09*
	M7	−3.5±0.14**	−0.13±0.25	−1.65±0.17**	1.23±0.27**	0.33±0.18*
18/18-like	M1	−3.38±0.14**	−0.47±0.25*	−1.29±0.18**	1.58±0.36**	––
	M6	−3.48±0.16**	−0.2±0.28	−0.98±0.64*	2.1±0.66**	−0.14±0.12
	M7	−3.38±0.13**	−0.47±0.25**	−1.38±0.18**	1.58±0.36**	0.29±0.21*
56/56-like	M1	−2.82±0.19**	−0.59±0.35*	−0.99±0.22**	0.72±0.38*	––
	M6	−3.05±0.24**	−0.35±0.4	−0.90±0.67*	0.7±0.51	−0.05±0.13
	M7	−2.82±0.19**	−0.58±0.35*	−1.03±0.25**	0.74±0.38**	0.09±0.25
Low risk	M1	−3.69±0.15**	−0.26±0.27	−1.31±0.21**	1.5±0.41**	––
	M6	−3.82±0.17**	0.05±0.29	−0.13±0.64	0.93±0.51*	−0.26±0.13**
	M7	−3.69±0.15**	−0.27±0.27	−1.42±0.22**	1.54±0.41**	0.33±0.24

Note:

*0.05≤p<0.1;

**p<0.05.u₀₀, β_00, u_11, and β₁₁ are related to the parameters in equation (2)

^a– the units of β₀₀ and β₁₁ are 1000/[C], where [C] are the units of CD4 cell counts, i.e., cells/mm³.

SEs were obtained by re-estimating the model in which probability at specific value of CD4 cell count was chosen as a model parameter instead of .